Not currently recruiting at UCSD
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
Summary
- Eligibility
- for people ages 18-45 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Jeremy Pettus, MD
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Jeremy Pettus, MD
Associate Professor Of Clinical, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 57 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Benaroya Research Institute
- ID
- NCT05281614
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated